Today (August 26th), Ansukang Medical (Suzhou) Co., Ltd. (hereinafter referred to as "Ansukang Medical") announced the completion of a new round of 100 million yuan financing. The round of financing is jointly invested by Taiping Innovation, Junlian Capital, and Shengjing Jiacheng. The funds raised from the financing will mainly be used for promoting the market of unmanned ultrasonic knives, building a new generation of energy platforms, and preparing production capacity.

Founded in 2020, Ansukang Medical has been focusing on the research and development of innovative medical devices since its establishment. It is an innovative medical device company based on its own core technology system, committed to providing Chinese medical workers with better and more convenient medical devices.

At present, the main product launched by Ansukang Medical is the new generation of non host ultrasonic knife, which is also the world's first split type non host ultrasonic knife. Compared with similar traditional products, it belongs to cross generation design and ranks first in the related technology field. It is also the only domestic brand in the field of ultrasonic knife that surpasses foreign brands in high integration technology. Currently, this ultrasonic knife has been widely used in soft tissue cutting and hemostasis in general surgery, urology, hepatobiliary surgery, thoracic surgery, breast surgery, gynecology, otolaryngology and other surgical departments.

This ultrasonic cutting tool has completely independent intellectual property rights and breaks the traditional design architecture of similar products. It adopts advanced design concepts and fully integrates the host, transducer, torque wrench, and connecting mechanism into one handle, achieving the miniaturization and intelligent development of ultrasonic cutting tools. Its main features are:

 No longer requiring a host, exempting medical units from the economic and labor costs of purchasing and maintaining related products (globally unique);
 The gear is integrated above the handle and can be adjusted by oneself, eliminating the need for a second person to adjust the gear of the product in the sterile area. It allows surgeons to quickly adjust the gear according to surgical needs in the sterile area, improving efficiency (the only one in the world);
 Optimization of cable position avoids the problem of cable winding and rebound caused by rotating blade heads, improving surgical safety and efficiency; The detachable design of the blade reduces the volume of medical waste that needs to be disposed of after a surgery by about 80% compared to traditional similar products, greatly reducing the cost of ultrasonic knife medical waste disposal; The remaining usage times of the handle can be displayed without power, making it more convenient for instrument cleaning and management, and no longer requiring the disinfection supply room to record it on its own (globally unique).

In addition, clinical feedback shows that the cutting speed of this unmanned ultrasonic knife is moderate, the operating experience is excellent, and its coagulation ability is particularly outstanding, able to close 5mm blood vessels. Meanwhile, gear adjustment and optimized cable settings greatly enhance the convenience of use. The host free design not only makes the equipment smaller and more intelligent, but also effectively reduces the comprehensive cost of using a single surgical ultrasound knife in hospitals.

It is worth mentioning that this ultrasonic knife obtained the Class III medical device registration certificate issued by the National Medical Products Administration in November 2022 and officially started sales in the second quarter of 2023. As of the first half of this year, the number of hospitals winning bids for centralized procurement has exceeded 100, and the overall number of admissions has exceeded 200.

Regarding this round of financing, Zhang Tao, founder of Ansukong, said, "We are very grateful for the recognition and support of Ansukong from both new and old shareholders. Since the launch of the unmanned ultrasound knife, it has quickly gained initial market recognition. This round of financing will help Ansukong accelerate the market share of unmanned ultrasound knives, accelerate the research and development process of new product lines, and create a differentiated product matrix. It will enable more medical workers to use better and simpler tools, reduce their burden in daily work, and better serve patients

Ultrasonic knife is a high-energy focused ultrasound instrument that works by utilizing the electrostriction effect or magnetostriction effect to convert ultrasonic electrical energy into mechanical energy. Through the amplification and coupling effect of the amplitude lever, the knife head is pushed to work and radiate energy to local tissues of the human body, thereby performing surgical treatment.

In the first half of 2024, the surgical market grew by 4.6% year-on-year, with the market for ultrasonic knives growing rapidly. Although the market growth has been increasing, the selection of ultrasonic knife products for hospitals and doctors is extremely limited, and the technology and market of ultrasonic knives are almost monopolized by foreign brands. Overseas large enterprises represented by Johnson&Johnson and Medtronic have been occupying over 80% of the market share in the field of ultrasound surgery for many years, and are in an absolute monopoly position. Domestic enterprises have a market share of less than 10%.

Therefore, the ultrasonic knife market is one of the largest segmented markets for domestic substitution space. With the rapid expansion of the ultrasonic knife industry in China, domestic brands continue to increase their innovation efforts, and the growth rate of the domestic brand market is significant, with a compound annual growth rate of 102.1% from 2016 to 2020.

With the acceleration of the domestic substitution process of ultrasonic knives in China, a number of innovative devices have also emerged. In addition to the world's first split type non host ultrasonic knife from Ankang Medical, the 7mm ultrasonic knife independently developed by Sino Micro has also been approved for market recently, becoming the first domestically produced 7mm ultrasonic knife approved for market in China; Mindray Medical has launched a new ultrasound high-frequency integrated surgical equipment, which assists doctors in completing surgeries accurately, efficiently, and conveniently through more precise ultrasound blade heads, more accurate intelligent algorithms, and other methods; There are also companies such as Beijing Sumai and Houkai Medical that focus on the research and development of ultrasonic knives.

Source: https://news.yaozh.com/archive/44080.html